Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma
Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma
Active, not recruiting · NCT02743819 · Registry updated 2025-06-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Phase 2 | 2025-06-10 | NCT02743819 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Chicago | 326 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Decatur Memorial Hospital | Decatur | United States | 303 |
| Fort Wayne Medical Oncology and Hematology, Inc. | Fort Wayne | United States | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | Tampa | United States | 32 |
| Illinois Cancer Care | Peoria | United States | 21 |
| Mount Sinai Medical Center of Florida | Miami Beach | United States | 5 |
| NorthShore University HealthSystem | Evanston | United States | 25 |
| Oncology Specialists S.C. | Park Ridge | United States | 1 |
| University of Chicago | Chicago | United States | 312 |
| University of South Alabama | Mobile | United States | 1 |
| Virginia Commonwealth University/ Massey Cancer Center | Richmond | United States | 1 |